Cardiol Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions CAD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cardiol Therapeutics Inc. (CRDL) - Annual data in millions CAD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2018
Current Assets
Cash and Cash Equivalents30.5834.9359.4783.9014.0316.73
Cash & Short-Term Investments30.5834.9359.4783.9014.0316.73
Accounts Receivable0.360.140.210.410.220.46
Inventory0.000.000.000.000.360.00
Other Current Assets0.730.941.492.830.350.00
Total Current Assets31.6736.1561.4487.1414.9524.03
Non-Current Assets
Property, Plant & Equipment (Net)0.200.340.300.360.480.03
Intangible Assets0.000.210.290.380.460.00
Other Non-Current Assets0.000.000.000.000.000.00
Total Non-Current Assets0.200.550.590.740.000.66
Total Assets31.8636.7062.0387.8815.8924.68
Current Liabilities
Accounts Payable6.987.628.354.861.772.14
Short-Term Debt0.030.000.000.000.000.00
Accrued Liabilities0.000.420.990.720.700.00
Other Current Liabilities0.000.240.426.660.000.00
Total Current Liabilities7.018.309.8011.572.522.14
Non-Current Liabilities
Long-Term Debt0.130.160.020.070.000.27
Other Non-Current Liabilities0.000.000.000.000.000.00
Total Non-Current Liabilities0.130.160.020.070.000.27
Total Liabilities7.148.459.8311.642.622.41
Stockholders' Equity
Common Stock179.34148.52147.55142.9251.920.00
Retained Earnings-179.25-142.58-114.45-83.52-51.88-17.55
Accumulated Other Comprehensive Income0.003.523.524.184.460.00
Additional Paid-in Capital24.6518.7915.5912.660.001.25
Shares Outstanding82.6165.3564.0461.920.000.00
Total Stockholders' Equity24.7328.2552.2076.2413.2722.27
Total Liabilities & Equity31.8636.7062.0387.880.0024.68